Niels Westergaard

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Chronic Kidney Disease

Clinical Decision Support

Genetic Diversity

Top Venues

Basic & clinical pharmacology & toxicology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology (2024)
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Steffen Jørgensen, Thorsten Brodersen, Ole Birger Vesterager Pedersen, Niels Westergaard
Distribution of the cytochrome P450 *alleles for CYP2C9 and CYP2C19 in a cohort of the Danish Blood Donor Study determined by using the Illumina Infinium Global Screening Array. Basic & clinical pharmacology & toxicology 135 (2) (2024)
Niels Westergaard, Morten Baltzer Houlind, Lona Louring Christrup, Helle Gybel Juul-Larsen, Charlotte Strandhave, Anne Estrup Olesen
Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization. Basic & clinical pharmacology & toxicology 134 (4) (2024)
Steffen Jørgensen, Thorsten Brodersen, Ole Birger Vesterager Pedersen, Niels Westergaard
Distribution of the cytochrome P450 *alleles for CYP2C9 and CYP2C19 in a cohort of the Danish Blood Donor Study determined by using the Illumina Infinium Global Screening Array. Basic & clinical pharmacology & toxicology (2024)
Steffen Jørgensen, Thorsten Brodersen, Ole Birger Vesterager Pedersen, Niels Westergaard
Distribution of the cytochrome P450 *alleles for CYP2C9 and CYP2C19 in a cohort of the Danish Blood Donor Study determined by using the Illumina Infinium Global Screening Array. Basic & clinical pharmacology & toxicology 135 (2) (2024)
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Niels Westergaard, Morten Baltzer Houlind, Lona Louring Christrup, Helle Gybel Juul-Larsen, Charlotte Strandhave, Anne Estrup Olesen
Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization. Basic & clinical pharmacology & toxicology 134 (4) (2024)
Niels Westergaard, Morten Baltzer Houlind, Lona Louring Christrup, Helle Gybel Juul-Larsen, Charlotte Strandhave, Anne Estrup Olesen
Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization. Basic & clinical pharmacology & toxicology (2024)
Niels Westergaard, Lise Tarnow, Charlotte Vermehren
Comparison of Multidrug Use in the General Population and among Persons with Diabetes in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Niels Westergaard, Lise Tarnow, Charlotte Vermehren
Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy. Metabolites 11 (2) (2021)